At Finecure, formulation development and regulatory compliance function as a single, unified system. Products engineered at our DSIR-recognised R&D centre scale seamlessly to commercial production using identical equipment trains-minimizing technical risk and accelerating time-to-market. Every batch is released against rigorous standards, aligned with official pharmacopoeial monographs or stringent in-house specifications. By embedding Quality by Design (QbD) principles across the entire product lifecycle, we ensure purity, safety, and consistent drug delivery are engineered into the process from day one.
A Formulation and Development team developing complex generics, modified-release systems and fixed-dose combinations, with technology transfer from laboratory to commercial scale.
Submit FormulationA quality management system built on Quality by Design, with end-to-end batch traceability, 21 CFR Part 11 data integrity and continuous audit-readiness against USFDA and WHO-GMP standards.
Discuss CDMO ManufacturingHPLC, GC and UV-Vis spectroscopy for method development, impurity profiling and release testing, with 24/7-monitored stability chambers running ICH studies across all climatic zones.
Submit Technical QueryA regulatory affairs division supporting market entry across 20+ countries with CTD, eCTD and ACTD dossiers, DMF support and ready-to-file in-licensing opportunities.
254 formulations across seven therapeutic verticals - oral solids, modified release, dispersible, liquids, sterile injectables and topicals.
Discuss CDMO & Out-LicensingFinecure provides formulation development, analytical validation and regulatory documentation as one service, so a partner entering a new market works with a single organisation from molecule to dossier.
Contact Business Development